October 25, 2014 3:33 AM ET

Biotechnology

Company Overview of RainDance Technologies, Inc.

Company Overview

RainDance Technologies, Inc. develops genomic tools for non-invasive liquid biopsy applications for the research, early detection, and treatment of cancer, inherited, and infectious diseases. It offers RainDrop, a digital polymerase chain reaction (PCR) solution; ThunderStorm, a targeted DNA sequencing system; ThunderBolts Cancer Panel, a DNA sequencing (NGS) solution that enables researchers to profile a range of tumor samples; peer-reviewed articles, including digital PCR, targeted DNA sequencing, and microdroplet applications articles, as well as technology reviews; and scientific posters, such as digital PCR and targeted DNA sequencing posters. The company serves major academic research ...

749 Middlesex Turnpike

Billerica, MA 01821

United States

Founded in 2004

Phone:

978-495-3300

Fax:

978-528-6090

Key Executives for RainDance Technologies, Inc.

Chief Executive Officer
Co-Founder and Chief Technology Officer
Co-Founder
Chief Financial Officer
Age: 60
Compensation as of Fiscal Year 2014.

RainDance Technologies, Inc. Key Developments

RainDance Technologies Names John Luckey as Vice President of Product Development

RainDance Technologies has appointed John Luckey, Ph.D., as its new vice president of product development. Dr. Luckey brings more than 20 years of experience leading teams tasked with developing biotechnology systems and technology platforms. During his career, he has held senior product and platform development positions in companies including Roche NimbleGen, where he directed research and development activities for improving and expanding the company's core DNA microarray synthesis technology and related instrumentation. Dr. Luckey also managed product development and engineering activities at MJ Research, contributing to the design and development of the Opticon product family and Opticon Monitor software.

RainDance Technologies Names Frederick L. Eibel as Senior Vice President of Strategic Marketing

RainDance Technologies announced the appointment of Frederick L. Eibel as its new Senior Vice President of Strategic Marketing. Mr. Eibel brings more than two and a half decades of broad-based in vitro diagnostics and life science experience focused primarily on new and emerging growth opportunities. He most recently served as Head of Genetic Analysis Commercial Operations at Agena Bioscience.

RainDance Technologies, Inc. Appoints Kathy Ordonez to Board of Directors

RainDance Technologies, Inc. announced the appointment of Kathy Ordoñez to its Board of Directors. Kathy Ordonez brings more than 30 years of experience in the life sciences and diagnostics industries. Ms. Ordonez was previously the Chief Executive Officer at Celera and a founder of Celera Diagnostics.

Similar Private Companies By Industry

Company Name Region
SARcode Bioscience Inc. United States
Paratek Pharmaceuticals, Inc. United States
Trellis Bioscience, Inc. United States
Samara Innovations, LLC United States
Functional Genetics, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact RainDance Technologies, Inc., please visit raindancetech.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.